Fasken is pleased to attend the 13th Annual Summit for Women in Life Sciences Law, which will bring together more than 300 attorneys and executives from the biotech, pharmaceutical, and medical device industries in Boston from July 29 to 30.
For over a decade, the summit has served as a premier forum for industry leaders from life sciences companies, law firms, associations, and government.
Our team, including Laurie Turner, Dara Jospé, Manpreet Singh, Eliane Ellbogen, and Camille Marceau, will be on site throughout the event to engage with key stakeholders in the sector.
About Fasken’s Life Sciences Group
Fasken’s Life Sciences team provides comprehensive support to life sciences clients throughout their lifecycle. Whether you’re a biotech startup, entering clinical trials, scaling up, expanding to new markets or exploring exit strategies, our team speaks your language. We know the unique challenges biotech and pharma companies face in securing and enforcing your patent portfolio, bringing a product to market, complying with Canada’s regulations, or raising funds across a competitive landscape. We have knowledgeable practitioners with advanced degrees in pharmaceutical sciences, clinical pharmacology, toxicology, and genetics. We know the sector.
Fasken lawyers and agents collaborate with our clients to provide advice tailored to your needs including marketing and product labelling, IP drafting and enforcement, competition, tax, litigation, contracts and agreements and a full range of corporate services from financings to M&A. Navigate complex challenges and bring your products to market in Canada with a team dedicated to your success. With a strong legal network in 47 countries, we also continue to be at the forefront of life sciences advancement and interests globally.
Fasken is ranked Band 1 by Chambers Canada for Life Sciences and is the most recognized Firm on The Globe & Mail’s list of Canada’s Best Law Firms 2025, being included in every category of Corporate Law and in Healthcare & Life Sciences and Intellectual Property.
For more information about Fasken’s Life Sciences Group, please contact Lina A. Lafortune at [email protected].
